Development of SARS-CoV-2 Nucleocapsid Specific Monoclonal Antibodies. - Terry JS; Anderson LB; Scherman MS; McAlister CE; Perera R; Schountz T; Geiss BJ (BioRxiv : the preprint server for biology, 2020)